CIO 2023
Real-world education from the Symposium on Clinical Interventional Oncology 2023, September 22-24, 2023, Orlando, FL, from the editors of GI Oncology Now
Histotripsy is an innovative modality for treating liver tumors that offers several advantages.
The number of arteries treated during transarterial chemoembolization did not affect outcomes in liver cancer patients.
Radiation lobectomy with transarterial embolization of Yttrium-90 is a viable option for hepatocellular carcinoma.
Durvalumab plus tremelimumab significantly improved overall survival in patients with unresectable liver cancer.
Advertisement
Advertisement
